Showing 5381-5390 of 21466 results for "".
- Pulmonary Hyalinizing Granuloma and Diagnostic Pitfallshttps://reachmd.com/news/pulmonary-hyalinizing-granuloma-and-diagnostic-pitfalls/2486674/Key Takeaways Incidentally detected pulmonary nodules in a 71-year-old man were described as mimicking metastatic disease on imaging. Surgical pathology identified fibrocollagenous nodules with perivascular inflammatory infiltrates, and immunohistochem
- Plant Based Dietary Patterns and Alzheimer Disease Riskhttps://reachmd.com/news/plant-based-dietary-patterns-and-alzheimer-disease-risk/2486658/Key Takeaways Plant-based dietary pattern quality was evaluated in association with incident Alzheimer disease and related dementias (ADRDs). Dietary change over time was also analyzed in relation to later ADRD risk. The authors framed the fin
- Cell-Assisted Lipotransfer Shows Potential in Facial and Breast Applications, Review Findshttps://reachmd.com/news/cell-assisted-lipotransfer-shows-potential-in-facial-and-breast-applications-review-finds/2486650/Cell-assisted lipotransfer (CAL) continues to evolve as an adjunct to conventional fat grafting, with a recent review in Annali Italiani di Chirurgia summarizing current evidence for its use in facial and breast procedures. CAL involves enrichment of autologous fat grafts with regenerati
- Meta-Analysis Links Hidradenitis Suppurativa With Higher Cancer Riskhttps://reachmd.com/news/meta-analysis-links-hidradenitis-suppurativa-with-higher-cancer-risk/2486646/A systematic review and meta-analysis of cancer incidence in hidradenitis suppurativa reported that hidradenitis suppurativa was associated with a higher overall cancer risk than gener
- Elraglusib Plus Chemotherapy Shows Survival Benefit in Pancreatic Cancerhttps://reachmd.com/news/elraglusib-plus-chemotherapy-shows-survival-benefit-in-pancreatic-cancer/2486644/In a randomized phase 2 study in metastatic pancreatic cancer, investigators reported longer survival with chemotherapy plus e
- Ultrasound Technologies Expand Role in Noninvasive Facial Rejuvenationhttps://reachmd.com/news/ultrasound-technologies-expand-role-in-noninvasive-facial-rejuvenation/2486640/Ultrasound-based energy devices continue to play an expanding role in noninvasive facial and neck rejuvenation, according to a recent review published online in Facial Plastic Surgery. The authors examine the evolution of high-intensity focused ultrasound (HIFU) into newer technologies s
- TONIC to Evaluate Early Nutrition After Emergency Abdominal Surgeryhttps://reachmd.com/news/tonic-early-nutrition-emergency-abdominal-surgery/2486631/Key takeaways: The TONIC trial is evaluating whether early parenteral nutrition after emergency abdominal surgery improves recovery and reduces complications. Results could directly influence postoperative nutritional guidelines in emergency surgery.</
- Stent Procedure Eases Post-Thrombotic Syndrome After DVThttps://reachmd.com/news/stent-post-thrombotic-syndrome-dvt/2486632/Key Takeaways In a randomized trial, severe post-thrombotic syndrome was less common at six months in the endovascular-treatment group (iliac vein stenting plus enhanced antithrombotic therapy) than in the standard-treatment group. The study enrolled p
- Epicutis Reports 8-Week Clinical Findings for New Hydrobiome Serumhttps://reachmd.com/news/epicutis-reports-8-week-clinical-findings-for-new-hydrobiome-serum/2486634/Epicutis has introduced Hydrobiome Serum, a new professional skincare product positioned for redness, congestion, and barrier disruption. The formulation centers on TCP, a proprietary isoprenyl cysteine compound developed by Signum Biosciences, and is paired with sodium tocopheryl phosphate, a wa
- Acquisition Broadens Newmedical’s Scar Care and Skincare Platformhttps://reachmd.com/news/strategic-acquisition-broadens-newmedicals-scar-care-and-skincare-platform/2486628/Newmedical Technology, Inc. announced its acquisition of Derma Made®, marking a strategic expansion of its dermatology and aesthetics portfolio, according to a news release from the company. The transaction will meld Newmedica